Biohaven director granted 68,693 stock options
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Biohaven Ltd. director Kishan Mehta received a grant of 68,693 stock options on April 28, 2026. Each option gives the right to buy one common share at an exercise price of $9.61 and expires on April 28, 2036.
According to the vesting terms, all 68,693 options will vest in full on the earlier of April 28, 2027 or the date of Biohaven’s 2027 Annual Meeting of Shareholders, provided Mehta continues to serve with the company through that vesting date.
Insider Trade Summary
Grant/Award: 68,693 shares
Grant/Award
1 txn
Insider
Mehta Kishan
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to buy) | 68,693 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to buy) — 68,693 options (Direct)
Holdings Before and After:
Stock Options (Right to buy), 0 to 68,693 options (Direct)
Footnotes (1)
- F1. The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date.
Key Figures
Options granted: 68,693 options
Exercise price: $9.61 per share
Expiration date: April 28, 2036
+1 more
4 metrics
Options granted
68,693 options
Grant to director on April 28, 2026
Exercise price
$9.61 per share
Stock options grant to director
Expiration date
April 28, 2036
End of option term
Vesting date
Earlier of April 28, 2027 or 2027 meeting
Full vesting subject to continuous service
Key Terms
Stock Options (Right to buy), exercise price, expiration date, vesting
4 terms
Stock Options (Right to buy) financial
"security_title: "Stock Options (Right to buy)""
exercise price financial
"conversion_or_exercise_price: "9.6100""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-04-28T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"shares subject to this stock option will vest in full on the earlier of"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Biohaven (BHVN) director Kishan Mehta report on this Form 4?
Director Kishan Mehta reported receiving a grant of 68,693 stock options in Biohaven Ltd. The options are a form of equity compensation, giving him the right to buy common shares at a fixed exercise price if and when they vest.
What are the key terms of the Biohaven (BHVN) stock options granted to Kishan Mehta?
The grant covers 68,693 stock options with an exercise price of $9.61 per share and an expiration date of April 28, 2036. Each option is exercisable for one common share once vesting conditions are satisfied, subject to continuous service requirements.
When do the newly granted Biohaven (BHVN) stock options vest for director Kishan Mehta?
All 68,693 options will vest in full on the earlier of April 28, 2027 or the date of Biohaven’s 2027 Annual Meeting of Shareholders. Vesting is conditioned on Mehta maintaining continuous service with the company through the applicable vesting date.
Does the Biohaven (BHVN) Form 4 show any stock sales by director Kishan Mehta?
The filing shows no stock sales. It reports a single transaction coded “A,” which reflects a grant or award of 68,693 stock options. This is a compensation-related acquisition of derivative securities rather than an open-market purchase or sale of common shares.
How many Biohaven (BHVN) options does Kishan Mehta hold after this reported grant?
After this transaction, the Form 4 shows Mehta directly holding 68,693 stock options linked to common shares. These options were granted at a $9.61 exercise price and are scheduled to vest in full in 2027, subject to his continued service with Biohaven.
AI-generated analysis. How Rhea-AI works. Not financial advice.
